Search Results (1 to 10 of 1682 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 458 Journal of Medical Internet Research
- 328 JMIR Research Protocols
- 186 JMIR Formative Research
- 124 JMIR mHealth and uHealth
- 80 JMIR Public Health and Surveillance
- 71 JMIR Mental Health
- 61 Online Journal of Public Health Informatics
- 57 JMIR Medical Informatics
- 39 JMIR Human Factors
- 36 JMIR Cancer
- 31 JMIR Dermatology
- 25 JMIR Aging
- 24 JMIR Medical Education
- 22 JMIR Pediatrics and Parenting
- 19 JMIR Cardio
- 18 JMIR Serious Games
- 17 Iproceedings
- 14 JMIR Diabetes
- 12 JMIR Infodemiology
- 11 Interactive Journal of Medical Research
- 9 JMIR Perioperative Medicine
- 9 JMIR Rehabilitation and Assistive Technologies
- 7 JMIR AI
- 6 JMIRx Med
- 6 Journal of Participatory Medicine
- 4 JMIR Nursing
- 3 JMIR XR and Spatial Computing (JMXR)
- 2 JMIR Biomedical Engineering
- 1 JMIR Bioinformatics and Biotechnology
- 1 JMIR Neurotechnology
- 1 Medicine 2.0
- 0 iProceedings
- 0 JMIR Preprints
- 0 JMIR Challenges
- 0 JMIR Data
- 0 JMIRx Bio
- 0 Transfer Hub (manuscript eXchange)
- 0 Asian/Pacific Island Nursing Journal
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
We retrospectively obtained EHR data from two sites: Beth Israel Deaconess Medical Center (BIDMC) and Massachusetts General Hospital (MGH), from 2010 to 2023. The EHR data contain clinical notes written by the clinician, ICD diagnosis codes (ICD-9 and ICD-10) assigned during encounters, and prescribed medications.
JMIR Med Inform 2025;13:e64113
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
While the development of aducanumab was discontinued earlier in 2024 (January 2024) [2], lecanemab and donanemab are currently under review for approval in Europe and worldwide [3], and lecanemab is already available for patients outside of the United States, including those in the United Kingdom, Japan, China, South Korea, Israel, and the United Arab Emirates [4-6].
J Med Internet Res 2025;27:e68454
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
(D) IUH: negative 5-Cog result.
At both sites, a paper token (Figure 4) is used as an additional feature to help ensure that care providers review the patients’ 5-Cog results. Patients are handed this token after they complete the 5-Cog battery and are asked to hand it to their care provider at their scheduled visit, generally within 30 minutes after the 5-Cog battery administration.
Token to alert care provider for patient's 5-Cog participation.
JMIR Res Protoc 2025;14:e60471
Download Citation: END BibTex RIS